Research and Markets: Research ELISA's Established Credentials Help it Weather Competition...

Research and Markets: Research ELISA's Established Credentials Help it Weather Competition from Multiplex Proteomic Arrays

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c88402) has announced the
addition of "U.S. Research ELISA Markets" to their offering.

This Frost & Sullivan research service titled U.S. Research ELISA
Markets provides revenue forecasts for the overall market. It provides
in-depth analyses of market-wide and segment-specific drivers,
restraints, and challenges, with the corresponding strategic
recommendations. In this research, Frost & Sullivan's expert analysts
thoroughly examine the following research ELISA markets: kits and
development components.

After a glorious 37-year run as a reliable and trusted technology
for analyte quantitation, the research enzyme-linked immunosorbent
assay (ELISA) technique has reached market maturity. It is drawing on
its entrenched reputation for quality results and reproducibility to
stave off the challenge mounted by newer multiplex proteomic array
technologies. This new-age technology scores over the single-analyte
quantitation technique of ELISA by offering high throughput capability
and allowing researchers to measure multiple analytes simultaneously.

"While the increased use of multiplex proteomic array technologies
has stalled the research ELISA market, new ELISA products remain
profitable at the provider level," says the analyst of this research
service. "Market participants are discovering that many laboratories
still prefer the ELISA technique or continue using the technology for
secondary validation after multiplexing." ELISA suppliers can also
position their products as the ideal tools for researchers that do not
need the advantages of multiplexing, focus only on a few analytes, and
require high assay sensitivity. This strategy can help diffuse the
threat of price instability, which is consequent to the
commoditization of products for popular analytes.

With over 60 participants serving in the ELISA market, it is vital
to focus new products on areas of research where multiplex arrays have
not been developed. "Many providers are expected to slow the expansion
of their ELISA portfolios or focus on niche markets and unique species
to circumvent growing competition from proteomic arrays," observes the
analyst. "ELISA providers must adapt their strategies to complement
multiplex platforms rather than try to compete head-on." Increasingly,
companies have opted to develop their own multiplex assay portfolios
to take advantage of the new technology and expand customer options.

Technologies

The following technologies are covered in this research:

- Antibody pre-coated 96-well microplates, enzyme concentrate,
diluents, wash buffer concentrate, substrate reagents, stop solution
and an assay protocol

- Antibody pair, standard and conjugate (usually Streptavidin-
horseradish peroxidase or alkaline phosphatase)

- Analyte (antigen, antibody, protein)

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following
market sectors in this research:

- Research ELISA kits

- Research ELISA development components

For more information visit
http://www.researchandmarkets.com/reports/c88402

Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980

Copyright Business Wire 2008